IAPP and type 2 diabetes mellitus: The peptide normally suppresses postprandial glucagon secretion, helps regulate gastric emptying, and induces satiety, thereby complementing the effects of insulin in glycemic control, but IAPP forms islet amyloid in T2D by an unknown mechanism [5]–[8].